Cantor Fitzgerald analyst Steve Seedhouse reiterated an Overweight rating and $266.00 price target on Belite Bio, Inc, ADR (NASDAQ: BLTE).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE